This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +3.45% and +0.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TMCIPositive Net Change HYPRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Globus Medical (GMED) delivered earnings and revenue surprises of +13.16% and +0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GMEDPositive Net Change ELMDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Identiv, Inc. (INVE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Identiv (INVE) delivered earnings and revenue surprises of +16.13% and -1.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
INVENegative Net Change PLUGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LegalZoom (LZ) Q2 Earnings Meet Estimates
by Zacks Equity Research
LegalZoom (LZ) delivered earnings and revenue surprises of 0.00% and +5.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LZPositive Net Change TPICNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
NerdWallet, Inc. (NRDS) Q2 Earnings Meet Estimates
by Zacks Equity Research
NerdWallet, Inc. (NRDS) delivered earnings and revenue surprises of 0.00% and -4.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NRDSNegative Net Change CANNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Assured Guaranty (AGO) Q2 Earnings Lag Estimates
by Zacks Equity Research
Assured Guaranty (AGO) delivered earnings and revenue surprises of -35.67% and +9.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AGONegative Net Change FIHLNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of +76.47% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AMNNegative Net Change ACONPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Artivion (AORT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Artivion (AORT) delivered earnings and revenue surprises of +118.18% and +4.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AORTNegative Net Change RPIDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Clean Energy Fuels (CLNE) Reports Break-Even Earnings for Q2
by Zacks Equity Research
Clean Energy Fuels (CLNE) delivered earnings and revenue surprises of +100.00% and +14.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CLNENo Net Change CWCONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
DocGo Inc. (DCGO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Motion Acquisition (DCGO) delivered earnings and revenue surprises of -83.33% and +4.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DCGOPositive Net Change SNDANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TTEC Holdings (TTEC) Lags Q2 Earnings Estimates
by Zacks Equity Research
TTEC (TTEC) delivered earnings and revenue surprises of -8.33% and +3.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TTECNegative Net Change DGXXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Diodes (DIOD) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Diodes (DIOD) delivered earnings and revenue surprises of +33.33% and +3.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DIODNegative Net Change PXLWNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Guild Holdings Company (GHLD) Q2 Earnings Top Estimates
by Zacks Equity Research
Guild (GHLD) delivered earnings and revenue surprises of +53.49% and -3.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GHLDPositive Net Change MRXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Mach Natural Resources LP (MNR) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Mach Natural Resources LP (MNR) delivered earnings and revenue surprises of +43.40% and +18.65%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MNRNegative Net Change KGEINo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
scPharmaceuticals (SCPH) delivered earnings and revenue surprises of -13.33% and -2.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SCPHNegative Net Change CUEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Puma Biotech (PBYI) delivered earnings and revenue surprises of +36.36% and +4.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PBYINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ePlus (PLUS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
ePlus (PLUS) delivered earnings and revenue surprises of +13.51% and +23.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PLUSNegative Net Change SPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Take-Two Interactive (TTWO) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Take-Two (TTWO) delivered earnings and revenue surprises of +125.93% and +10.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TTWONegative Net Change PVHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Celldex (CLDX) delivered earnings and revenue surprises of +1.16% and -56.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CLDXNegative Net Change YMABPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
CRINETICS PHARM (CRNX) delivered earnings and revenue surprises of -8.85% and -79.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CRNXPositive Net Change CASINo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Integral Ad Science (IAS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Integral Ad Science (IAS) delivered earnings and revenue surprises of +75.00% and +3.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IASPositive Net Change BNZIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Kratos (KTOS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Kratos (KTOS) delivered earnings and revenue surprises of +22.22% and +14.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KTOSNegative Net Change ESLTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
OptimizeRx (OPRX) delivered earnings and revenue surprises of +700.00% and +30.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
OPRXNegative Net Change SPNSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Alta Equipment (ALTG) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Alta Equipment (ALTG) delivered earnings and revenue surprises of +22.22% and +0.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALTGNegative Net Change BWENNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Sutro Biopharma (STRO) delivered earnings and revenue surprises of +64.10% and +293.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
STROPositive Net Change ANIPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank